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Aim of the study:
The first  aim of the observational study “ONCOGER” would  be to 
evaluate elderly patients receiving chemotherapy 
1.the acute impact (maximum of 30 days after the end of the first cycle of 
therapy) of the treatment on the cognitive functions and on the quality of 
life 
2. the possible correlation between emotional status and  change on the 
cognitive functions after treatment   
By documenting the changes in these aspects, we would be better able to 
understand how chemotherapy may affect life and tolerance level of older 
patients, who are sometimes under-treated.
This information can help us to provide optimal cancer therapy and 
adequate supportive care to older people who undergo chemotherapy.
Statistical methods:
Descriptive data on patients’ demographic characteristics were 
assessed at the beginning of the study. 
All test score was summarized by means and standard deviation 
at baseline (T1) and after the first 12 weeks of treatment (T2).
Changes after therapy in MMSE, Clock Test and the other 
evaluations on  cognitive function are graphically evaluated. 
For the possible correlation between emotional status and the 
score in same cognitive test, like verbal fluency test, matrix care 
test and  clock test, changes in this test are evaluated among 
patients with light or heavy depression (GDS>6) at T2. 
Study Design:
This is an observational study.
Patients aged 70 years or older with solid tumor who are candidates to 
chemotherapy will be proposed to enter in the study, that is based on the 
collaboration of geriatricians and medical oncologists, in order to have a 
comprehensive approach to the treatment of the tumor and of the older 
patients. Before and after 12 weeks of treatment the patients will be 
followed in order to perform geriatric assessments which will allow to better 
define the cognitive functions of the patient and to detect the acute effect of 
chemotherapy on this domain.
Measurements: 
Physical function was measured by the Eastern Cooperative Oncology 
Group performance status (ECOG PS). Scores on the ECOG PS range 
from 0 (fully independent) to 4 (totally bedridden).
The cognitive functions will be investigated by the Mini-Mental State 
Examination (MMSE) and the Clock Test. The first investigates the 
mental health using a 30 items questionnaire  that evaluates some specific 
areas of the cognitive domain. In particular it detects space-temporal 
orientation, short time memory, attention, apraxia, comprehension and 
verbal fluidity.
The MMSE score ranges from 0 to 30, the higher the score on the MMSE 
is, the better is the cognition, scores >24 are considered abnormal.
The only analysis of the Mini-Mental total score does not allow to detect if 
there are specific sub-areas of the cognitive domain particularly affected by 
the treatment. For this reason, it was performed a comprehensive
evaluation of the cognitive domain through specific tests. 
The sub-area test, with threshold of normality are reported in the table
below
The Clock test values the space-visual ability and the problem-solving 
capability. The score ranges from 0 to 9 and score >6 are considered 
abnormal.  Patient’s Quality of life (QOL) was measured with 27-items 
questionnaire  (FACT-G) divided in 4 subscales: physical well-being, social 
family well-being, emotional well-being and functional well-being. The sum 
of subscale score gives the total score of the test (range 0-108), the higher 
the score is , the better is the QOL. The Geriatric Depression Scale 
(GDS) questionnaire was performed to measure the emotional domain. 
The score ranging from 0 to 15 and values between 6 and 10 indicate 
presence of a light depression, score <10 indicates heavy depression. 
Results:
Of 87 patients entered in the study 
only 30 are resulted valuable in
this first phase, 19 females and 
11 males.
The average age was 75.7 years 
(range 70-82). 24 patients were 
affected by an advanced tumor. 
At T1 16 (59%) patients had an 
ECOG-PS of 0 and 7 (26%)
scored 1 point.
We find that the means score are lower after the treatment 
for all test except for the clock test.
We report the distribution of changes in the geriatric 
assessment scores after the chemotherapy
We observed that one-half 
of patients, after receiving 
chemotherapy  had lower 
scores in: MMSe,15 words 
of Ray-immediate recall, 
verbal fluency and Matrix 
care tests.
Most patients (57%) had no 
score changes on Clock test 
and Copy design (50%).
In the graph we report the relationship between the GDS 
score and the correlate cognitive test 
The GDS test gives 12 patients with depression at T0 and 15 
at T1.
The GDS means that the score
at T0 is 5.13, at T1 6.07.  
8 of 15 patients with depression 
after therapy had a pathologic 
score also at the clock test, 
5 of these had just at T0 a
pathologic score.
For the other tests there is no 
evidence of improvement due to  
the presence of depression.
Discussions:
This study was limited by the small sample size and the short 
follow-up period due to its pilot nature.
The results of the current study revealed that cancer patients
aged 70 years and older who were treated experienced limited 
deteriorations in functional and emotional measurements
after receiving chemotherapy.
This results will be the basis to design a more complete and 
adequately sized study.
There are data suggesting that chemotherapy may have a negative impact on cognitive function; on the other hand, aging itself causes changes in the 
cognitive domain. This area is commonly evaluated in the context of a comprehensive geriatric assessment (GCA) by the Mini-mental state examination 
(MMSe). (Chen H. et al., 2002)
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